Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 9;10(1):e23436.
doi: 10.1016/j.heliyon.2023.e23436. eCollection 2024 Jan 15.

Prognostic factors affecting long-term outcomes in patients with concurrent IgA nephropathy and membranous nephropathy

Yunlong Qin  1   2 , Zixian Yu  1 , Hao Wu  1 , Anjing Wang  1 , Fang Wang  2 , Di Wang  1 , Qing Jia  1 , Jinguo Yuan  1 , Yan Xing  1 , Yumeng Zhang  1 , Jin Zhao  1 , Shiren Sun  1
Affiliations

Prognostic factors affecting long-term outcomes in patients with concurrent IgA nephropathy and membranous nephropathy

Yunlong Qin et al. Heliyon. .

Abstract

Background: The incidence of concurrent immunoglobulin A nephropathy and membranous nephropathy (cIgAN/MN) is low and rarely reported, and the prognosis of patients with cIgAN/MN remains unclear. This study was designed to compare the clinical and prognostic characteristics of cIgAN/MN with IgAN and MN and to identify crucial factors influencing the outcomes of patients with cIgAN/MN.

Methods: We included biopsy-proven cIgAN/MN patients between December 2012 and December 2020 at Xijing Hospital. In the same period, propensity score matching was employed to select an equal number of IgAN and MN patients according to the following criteria: age, sex, and follow-up time. The primary endpoint was defined as a composite of eGFR decline ≥30 %, end-stage renal disease, or death. The patient survival rate was examined using Kaplan-Meier survival curves. Univariate and multivariate Cox regression analysis models were utilized to identify the risk factors affecting renal prognosis.

Results: A total of 135 patients were finally included in this study and 35 (25.9 %) reached the primary endpoint. The median follow-up time of cIgAN/MN was 45.9 (24.0, 72.0) months. Compared to the IgAN group, the cIgAN/MN group exhibited a lower cumulative incidence rate of composite renal endpoints (P = 0.044), while no significant difference was found between MN and cIgAN/MN patients (P = 0.211). Univariate Cox analysis revealed that mean arterial pressure, serum potassium, blood urea nitrogen, serum IgA, segmental glomerulosclerosis (S1), and MN staging were associated with an increased risk of renal composite endpoints. The multivariate Cox regression analysis of clinical variables plus histological lesion scoring demonstrated that potassium (HR = 14.350, 95 % CI 2.637-78.090, P = 0.002), serum IgA (HR = 1.870, 95 % CI 1.109-3.153, P = 0.019), and S1 (HR = 11.965, 95 % CI 2.166-66.105, P = 0.004) were independent risk factors influencing renal outcomes in cIgAN/MN patients.

Conclusion: The prognosis of cIgAN/MN patients may exhibit an intermediate pattern between IgAN and MN, leaning towards being more similar to MN in certain aspects. Within the cIgAN/MN cohort, potassium, and serum IgA may be more predictive of rapid progression of renal endpoints, and S1 may indicate a more aggressive disease course.

Keywords: Chronic kidney disease; Concurrent IgAN and MN; Prognostic model; Risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Inclusion flowchart. IgAN, immunoglobulin A nephropathy. MN, membranous nephropathy. cIgAN/MN, concurrent IgAN and MN. PSM, propensity score matching.
Fig. 2
Fig. 2
Kidney biopsy pathological results of cIgAN/MN. (A, B) Light microscopy image showing thickened glomerular basement membranes, segmental glomerulosclerosis, spike-like projection, and fuchsin deposition in mesangial and subepithelial regions (arrows; periodic acid-silver methenamine, 400 × and 1000 × ). (C) Immunofluorescence staining for IgA (400 × ). (D) Immunofluorescence staining for IgG (400 × ). (E) Immunofluorescence staining for C3 (400 × ). (F) Electron microscopy showed thickening of glomerular basement membrane (600–700 nm), deposition of electron-dense material in subepithelial, intra-basement membrane and mesangial areas, and extensive fusion of foot processes (4000 × ).
Fig. 3
Fig. 3
Kaplan-Meier survival curves for free of combined events of different groups. (A) Cumulative poor event-free renal survival rate. (B) Cumulative incidence of urinary protein PR or CR. IgAN, immunoglobulin A nephropathy. MN, membranous nephropathy. cIgAN/MN, concurrent IgAN and MN.
Fig. 4
Fig. 4
Survival curve of cIgAN/MN patients under different factors. (A) MAP, mean arterial pressure. (B) K, potassium. (C) serum IgA. (D) S1, segmental glomerulosclerosis.
figs1
figs1
See this image and copyright information in PMC

References

    1. Yang C., et al. Executive summary for China kidney disease network (CK-NET) 2016 annual data report. Kidney Int. 2020;98(6):1419–1423. - PubMed
    1. Zhao J., et al. Low-dose corticosteroid combined with mycophenolate mofetil for IgA nephropathy with stage 3 or 4 CKD: a retrospective cohort study. Clin. Therapeut. 2021;43(5):859–870. - PubMed
    1. Caza T.N., et al. Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. Kidney Int. 2023;103(3):593–606. - PMC - PubMed
    1. Zhang J., et al. A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy. Exp. Ther. Med. 2020;20(4):3130–3137. - PMC - PubMed
    1. Doi T., et al. 1983. An Overlapping Syndrome of IgA Nephropathy and Membranous Nephropathy? pp. 24–30. - PubMed